Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel

Colloids and Surfaces B: Biointerfaces

Volumn 143, Issue , 2016, Pages 47-55

  Sun, Bingjun ^a   Luo, Cong ^a   Li, Lin ^a   Wang, Menglin ^a   Du, Yuqian ^a   Di, Donghua ^a   Zhang, Dong ^a   Ren, Guolian ^a   Pan, Xiaolei ^b   Fu, Qiang ^a   Sun, Jin ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Core match; Docetaxel; Lipophilic prodrug; Nanostructured lipid carriers; Oral delivery

Indexed keywords

BIOCHEMISTRY; MOLECULAR BIOLOGY; PARTICLE SIZE;

CORE-MATCH; DOCETAXEL; NANOSTRUCTURED LIPID CARRIERS; ORAL DELIVERY; PRODRUGS;

DRUG PRODUCTS;

CLATHRIN; DOCETAXEL; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; OLEIC ACID; UNCLASSIFIED DRUG; ACYLGLYCEROL; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; DRUG CARRIER; PRODRUG; TAXOID; TOCOFERSOLAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORE MATCH ENCAPSULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; ENDOCYTOSIS; INTESTINE WALL; MAXIMUM PLASMA CONCENTRATION; MEMBRANE PERMEABILITY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BIOAVAILABILITY; CHEMICAL PHENOMENA; CHEMISTRY; DOG; DRUG EFFECTS; DRUG FORMULATION; INTESTINE; INTESTINE ABSORPTION; MDCK CELL LINE; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; SYNTHESIS; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; DOGS; DRUG CARRIERS; DRUG COMPOUNDING; ENDOCYTOSIS; GLYCERIDES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTESTINAL ABSORPTION; INTESTINES; MADIN DARBY CANINE KIDNEY CELLS; NANOSTRUCTURES; OLEIC ACIDS; PARTICLE SIZE; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; TAXOIDS; TISSUE DISTRIBUTION; VITAMIN E;

EID: 84964612424     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.02.065     Document Type: Article

References (26)

1. Mei L., Zhang Z., Zhao L., Huang L., Yang X.L., Tang J., Feng S.S. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv. Drug Deliv. Rev. 2013, 65:880-890.
2. Cho H.J., Park J.W., Yoon I.S., Kim D.D. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int. J. Nanomed. 2014, 9:495-504.
3. Luo C., Sun J., Du Y., He Z. Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy. J. Control. Release 2014, 176:94-103.
4. Liu D., Liu Z., Wang L., Zhang C., Zhang N. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B Biointerfaces 2011, 85:262-269.
5. Lee M.K., Lim S.J., Kim C.K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007, 28:2137-2146.
6. Yan Y.D., Kim D.H., Sung J.H., Yong C.S., Choi H.G. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Int. J. Pharm. 2010, 399:116-120.
7. Wong H.L., Bendayan R., Rauth A.M., Li Y., Wu X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Deliv. Rev. 2007, 59:491-504.
8. Yuan H., Chen C.Y., Chai G.H., Du Y.Z., Hu F.Q. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol. Pharm. 2013, 10:1865-1873.
9. Zheng J., Wan Y., Elhissi A., Zhang Z., Sun X. Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles. Pharm. Res. 2014, 31:2220-2233.
10. Ma Y., Liu D., Wang D., Wang Y., Fu Q., Fallon J.K., Yang X., He Z., Liu F. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. Mol. Pharm. 2014, 11:2623-2630.
11. Wang Y., Wang D., Fu Q., Liu D., Ma Y., Racette K., He Z., Liu F. Shape-controlled paclitaxel nanoparticles with multiple morphologies: rod-shaped, worm-like, spherical, and fingerprint-like. Mol. Pharm. 2014, 1:3766-3771.
12. Wang D., Fu Q., Tang B., Hackett M., Wang D., Liu F. Molecular-matched materials for anticancer drug delivery and imaging. Nanomedicine (Lond.) 2015, 10:3003-3013.
13. Iqbal M.A., Md S., Sahni J.K., Baboota S., Dang S., Ali J. Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target. 2012, 20:813-830.
14. Zhao H., Lu H., Gong T., Zhang Z. Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity. Int. J. Nanomed. 2013, 8:1959-1973.
15. Wang J., Sun J., Chen Q., Gao Y., Li L., Li H., Leng D., Wang Y., Sun Y., Jing Y., Wang S., He Z. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials 2012, 33:6877-6888.
16. Ke X.Y., Zhao B.J., Zhao X., Wang Y., Huang Y., Chen X.M., Zhao B.X., Zhao S.S., Zhang X., Zhang Q. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat. Biomaterials 2010, 31:5855-5864.
17. Gu Y., Zhong Y., Meng F., Cheng R., Deng C., Zhong Z. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Biomacromolecules 2013, 14:2772-2780.
18. Liu D., Liu F., Liu Z., Wang L., Zhang N. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol. Pharm. 2011, 8:2291-2301.
19. Fang G., Tang B., Chao Y., Xu H., Gou J., Zhang Y., Xu H., Tang X. Cysteine-functionalized nanostructured lipid carriers for oral delivery of docetaxel: a permeability and pharmacokinetic study. Mol. Pharm. 2015, 12:2384-2395.
20. Namgung R., Zhang Y., Fang Q.L., Singha K., Lee H.J., Kwon I.K., Jeong Y.Y., Park I.K., Son S.J., Kim W.J. Multifunctional silica nanotubes for dual-modality gene delivery and MR imaging. Biomaterials 2011, 32:3042-3052.
21. Wang M., Sun J., Zhai Y., Lian H., Luo C., Li L., Du Y., Zhang D., Ding W., Qiu S., Liu Y., Kou L., Han X., Xiang R., Wang Y., He Z. Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. Biomacromolecules 2015, 16:1179-1190.
22. Zhang D., Pan X., Wang S., Zhai Y., Guan J., Fu Q., Hao X., Qi W., Wang Y., Lian H., Liu X., Wang Y., Sun Y., He Z., Sun J. Multifunctional poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-beta-cyclodextrin amphiphilic copolymer as an oral high-Performance delivery carrier of tacrolimus. Mol. Pharm. 2015, 12:2337-2351.
23. Yuan L., Jian W., Zhang D., Aubry A.F., Arnold M.E. Application of a stabilizer cocktail of N-ethylmaleimide and phenylmethanesulfonyl fluoride to concurrently stabilize the disulfide and ester containing compounds in a plasma LC-MS/MS assay. J. Pharm. Biomed. Anal. 2014, 88:552-561.
24. Harde H., Das M., Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 2011, 8:1407-1424.
25. Pandita D., Ahuja A., Lather V., Benjamin B., Dutta T., Velpandian T., Khar R.K. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel. AAPS PharmSciTech 2011, 12:712-722.
26. Chai G.H., Xu Y., Chen S.Q., Cheng B., Hu F.Q., You J., Du Y.Z., Yuan H. Transport mechanisms of solid lipid nanoparticles across caco-2Cell monolayers and their related cytotoxicology. ACS Appl. Mater. Interfaces 2016.